Abstract
Background: Thymectomy (Tx) is a common therapeutic option to treat myasthenia gravis (MG), but its effects on the immune system are still obscure in humans. Objective: We sought to evaluate long-term immunologic effects of therapeutic Tx in patients with MG. Methods: T- and B-cell subsets and T-cell repertoire were analyzed in 35 patients with MG, 16 with previous Tx (at least 8 years before), 6 with recent (+ and CD8+ T cells. They displayed a normal number of total B and CD5+ B-circulating lymphocytes, but they also displayed a polyclonal increase in serum IgM and IgG associated with the presence of high levels of a variety of organ- and nonorgan-specific autoantibodies, including anti-dsDNA and anticardiolipin, without clinical evidence of autoimmune disease. These serologic abnormalities were not detectable in both non-Txd and recently Txd patients. After 3 years, 2 long- term Txd patients had systemic lupus erythematosus and an undifferentiated connective tissue disease. Conclusions: The association between MG and laboratory findings of systemic autoimmune disease may be in part related to Tx rather than to MG. Tx may represent a risk for the development of systemic autoimmune disorders over years in patients with MG.
Original language | English |
---|---|
Pages (from-to) | 865-872 |
Number of pages | 8 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 103 |
Issue number | 5 I |
DOIs | |
Publication status | Published - 1999 |
Keywords
- Anti- DNA
- Anticardiolipin
- B cell
- Myasthenia gravis
- Systemic lupus erythematosus
- T cell
- Thymectomy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology